Neurosciences Clinical Trial
Official title:
MONITORING OF REALITY AND DOPAMINE: A PHARMACOLOGICAL RESEARCH
Reality-monitoring characterizes the ability to determine whether information was perceived in the environment or only imagined . Impaired reality-monitoring abilities have been associated with hallucinations in patients with schizophrenia and patients with Parkinson's disease. The investigators hypothesize a link between dopaminergic (DA) transmission and reality-monitoring.
This hypothesis is based on several studies in the literature: 1) DA transmission anomalies are observed in both schizophrenia and Parkinson's disease; 2) DA agonists may induce hallucination; 3) DA antagonists reduce hallucinations and improve reality-monitoring abilities in patients with schizophrenia. In addition, also suggesting a link between mesocorticolimbic connectivity, subcortical DA transmission and reality-monitoring, The investigators have shown that fronto-temporal transcranial Direct Current Stimulation (tDCS) leads: - on the one hand, to modulate reality-monitoring performance in healthy volunteers and patients; - on the other hand, to induce subcortical DA release. However, to date, no study has yet explored the direct link between DA transmission and reality-monitoring. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05618990 -
OPTIMIZATION of ADVANCED MR SEQUENCES
|
||
Recruiting |
NCT05324579 -
Studying the Neuronal Basis of Human Social Cognition
|
N/A | |
Completed |
NCT04868929 -
The Brain Activation During Different Motor Patterns in Healthy Adults
|
||
Completed |
NCT03944954 -
Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults
|
Early Phase 1 | |
Completed |
NCT04905186 -
Different Domains of Executive Function Dual Task Walking on Brain Activation and Gait Performance in Healthy Adults
|